Madrigal Pharmaceuticals, Inc.
(NASDAQ : MDGL)

( )
MDGL After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -2.58%24.9214.1%$146.63m
ICLRICON plc -0.44%255.922.8%$144.79m
HZNPHorizon Therapeutics Plc -1.67%86.575.4%$106.97m
CTLTCatalent, Inc. -0.48%102.072.0%$104.75m
BHCBausch Health Cos., Inc. -2.58%24.920.0%$102.00m
SAVACassava Sciences, Inc. -9.13%37.410.0%$90.10m
JAZZJazz Pharmaceuticals Plc -1.07%139.132.1%$86.34m
UTHRUnited Therapeutics Corp. -2.49%199.9713.9%$78.20m
ZGNXZogenix, Inc. 0.31%26.007.5%$67.37m
ARGXargenx SE 0.99%281.480.0%$50.38m
PRGOPerrigo Co. Plc -0.18%39.736.9%$48.99m
PCRXPacira Biosciences, Inc. -0.41%64.009.8%$28.57m
BRBRBellRing Brands, Inc. -2.02%24.250.0%$26.01m
IRWDIronwood Pharmaceuticals, Inc. -2.41%10.929.5%$22.19m
CORTCorcept Therapeutics, Inc. -2.35%17.475.5%$18.09m

Company Profile

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.